• The Journal of Advanced Prosthodontics
• /
• 제13권6호
• /
• pp.361-372
• /
• 2021

PURPOSE. To improve the clinical effects of complete denture use and simplify its clinical application, a digital complete denture restoration workflow (Functional Suitable Digital Complete Denture System, FSD) was proposed and preliminary clinical evaluation was done. MATERIALS AND METHODS. Forty edentulous patients were enrolled, of which half were treated by a prosthodontic chief physician, and the others were treated by a postgraduate student. Based on the primary impression and jaw relation obtained at the first visit, diagnostic denture was designed and printed to create a definitive impression, jaw relation, and esthetic confirmation at the second visit. A redesigned complete denture was printed as a mold to fabricate final denture that was delivered at the third visit. To evaluate accuracy of impression made by diagnostic denture, the final denture was used as a tray to make impression, and 3D comparison was used to analyze their difference. To evaluate the clinical effect of FSD, visual analogue scores (VAS) were determined by both dentists and patients. RESULTS. Two visits were reduced before denture delivery. The RMS values of 3D comparison between the impression made via diagnostic dentures and the final dentures were 0.165 ± 0.033 mm in the upper jaw and 0.139 ± 0.031 mm in the lower jaw. VAS ratings were between 8.5 and 9.6 in the chief physician group, while 7.7 and 9.5 in the student group; there was no statistical difference between the two groups. CONCLUSION. FSD can simplify the complete denture restoration process and reduce the number of visits. The accuracy of impressions made by diagnostic dentures was acceptable in clinic. The VASs of both dentists and patients were satisfied.

• 폴리머
• /
• 제34권6호
• /
• pp.527-533
• /
• 2010

Pioglitazone을 봉입한 poly(lactide-co-glycolide)(PLGA) 나노입자를 emulsion-evaporation 방법을 이용하여 제조하여 최적의 나노입자와 봉입률을 조절하였다. 제조된 나노입자의 크기는 125~170 nm이었으며 30% pioglitazone이 봉입된 나노입자(3% PVA)의 봉입률은 85% 이상이었다. 이러한 나노입자들은 40일 동안 일정하게 용출이 되었다. 당뇨병 모델을 이용한 동물실험에서 글루코오스 농도를 저하시켰을 뿐만 아니라, 조직검사에서는 낮은 독성을 가지고 있는 것을 확인하였다. 이러한 결과는 pioglitazone 경구투여를 위한 약물전달을 위한 운반체로 사용될 수 있음을 확인하였다.

• Journal of Pharmaceutical Investigation
• /
• 제33권3호
• /
• pp.179-185
• /
• 2003

Melatonin (MT) is an indole amide pineal hormone. It has not only very short half-life but also pH-sensitive property. The sustained release dosage form which delivers MT in a circadian fashion over 8 h is clinical value. The purpose of this study is to prepare sugar beads using multiple coating methods and enteric-coated in a sustained release to evaluate in vitro release characteristics in simulated gastric and intestinal fluids. The $Eudragit^{\circledR}$ as a polymer, sustained release membrane, and triethylcitrate (TEC) as a plasticzer were used. Multi-coated melatonin delivery system was composed of sugar, various excipients, $Eudragit^{\circledR}$ and enteric materials (e.g. hydroxy propyl methyl cellulose phthalate, HPMCP), and prepared by fluid bed coater. The dissolution test was carried out using the basket method at a stirring speed of 100 rpm at $37^{\circ}C$ in simulated gastric (pH 1.2) and intestinal fluid (pH 7.4). The released amount of MT was determined by High performance liquid chromatography method. The morhologies of surface and cross section of multi-coated beads were observed by scanning electron microscope. Size of multi-coated sugar beads was ranged over $1000{\sim}1300\;{\mu}m$. The release rate of MT from coated beads was limited in simulated gastric fluid (pH 1.2), but it was sustained in intestinal fluid (pH 7.4) during $3{\sim}8$ hours. The MT beads may provide small-intestine-targeted device for oral delivery. Studies on animal and relative experiment are in process.

• Journal of Pharmaceutical Investigation
• /
• 제36권6호
• /
• pp.363-369
• /
• 2006

Granisetron is a selective 5-HT3 receptor antagonist that is used therapeutically for the prevention of vomiting and nausea associated with emetogenic cancer chemotherapy. Although this drug is commercially available for intravenous and oral dosage, there is a need for intranasal delivery formulations in specific patient populations in which the use of these dosage forms may be unfeasible and/or inconvenient. A rapid and specific high-performance liquid chromatography method with mass spectrometric detection(LC-MS) was developed and validated for the analysis of granisetron in plasma after nasal administration in rats. This method has been validated for concentrations ranging from 5 to 1000 ng/ml with simple treatment. This technique has high level reproducibility, accuracy, and sensitivity. The method described was found to be suitable for the analysis of all samples collected during preclinical pharmacokinetic investigations of granisetron in rats after nasal administration. This study was aimed to investigate the feasibility of nasal delivery of granisetron for the elimination of vomiting. The effects of osmolarity, dosage volume at the same dose and applied dose on the nasal absorption of granisetron in rats were observed. No significant difference in the effect of osmolarity and dosage volume at the same dose was observed. As the applied dose of granisetron in nasal formulation increased, the absorption increased linearly. Based on these results it appears that only the applied dose(drug mass) determines the nasal absorption of granisetron. The bioavailability of granisetron on nasal administration of 4 mg/kg appeared to be comparable to that of intravenous administration of the same dose. These results suggest that granisetron can be efficiently delivered nasally and the development of nasal formulation will be feasible.

• 대한핵의학회지
• /
• 제38권2호
• /
• pp.152-160
• /
• 2004

Radioiodide uptake in thyroid follicular epithelial cells, mediated by a plasma membrane transporter, sodium iodide symporter (NIS), provides a first step mechanism for thyroid cancer detection by radioiodide injection and effective radioiodide treatment for patients with invasive, recurrent, and/or metastatic thyroid cancers after total thyroidectomy. NIS gene transfer to tumor cells may significantly and specifically enhance internal radioactive accumulation of tumors following radioiodide administration, and result in better tumor control. NIS gene transfers have been successfully performed in a variety of tumor animal models by either plasmid-mediated transfection or virus (adenovirus or retrovirus)-mediated gene delivery. These animal models include nude mice xenografted with human melanoma, glioma, breast cancer or prostate cancer, rats with subcutaneous thyroid tumor implantation, as well as the rat intracranial glioma model. In these animal models, non-invasive imaging of in vivo tumors by gamma camera scintigraphy after radioiodide or technetium injection has been performed successfully, suggesting that the NIS can serve as an imaging reporter gene for gene therapy trials. In addition, the tumor killing effects of I-131, ReO4-188 and At-211 after NIS gene transfer have been demonstrated in in vitro clonogenic assays and in vivo radioiodide therapy studies, suggesting that NIS gene can also serve as a therapeutic agent when combined with radioiodide injection. Better NIS-mediated imaging and tumor treatment by radioiodide requires a more efficient and specific system of gene delivery with better retention of radioiodide in tumor. Results thus far are, however, promising, and suggest that NIS gene transfer followed by radioiodide treatment will allow non-invasive in vivo imaging to assess the outcome of gene therapy and provide a therapeutic strategy for a variety of human diseases.

• The Korean Journal of Pain
• /
• 제22권1호
• /
• pp.68-73
• /
• 2009

Opioids profoundly inhibit evoked discharges of spinal nociceptive neurons, thereby inhibiting the transmission of pain. Intrathecal administration of opioids using implantable continuous infusion systems is an effective method of pain relief when other treatments have failed, as well as for patients with adequate analgesia on high dose therapy that produces unacceptable side effects. We report two cases of intrathecal pump implantation performed in patients suffering from intractable chronic pain. A test dose of 3 mg morphine was injected into the epidural space. No side effects were noted and patients experienced considerable pain relief. Implantation was performed one day after the test. The initial intrathecal morphine delivery dose was half of the equivalent dose of daily oral intake opioids and the infusion rate was increased gradually under close observation for opioid side effects. Two days post-implantation, both patients were discharged without any complications.

• Korean Chemical Engineering Research
• /
• 제43권2호
• /
• pp.299-304
• /
• 2005

음이온 하이드로젤은 그들이 가지고 있는 pH 감응성 팽윤거동 때문에 단백질 약물의 경구투여용 전달물질로써 많은 주목을 받고 있다. 본 연구에서는 음이온 하이드로젤의 pH 변화에 따른 용매의 침투 메커니즘을 규명하기 위하여 methacrylic acid와 2-methacryloxyehtyl glucoside를 공중합하여 P(MAA-co-MEG) 하이드로젤을 합성한 후 pH 변화에 따른 하이드로젤의 동적 팽윤거동을 관찰하였다. 용매의 침투 메커니즘이 Fickian 또는 non-Fickian 인지를 설명할 수 있는 특성지수 n을 $M_t/M_{\infty}=kt^n$ 관계식으로부터 계산하였다. 하이드로젤에 대한 용매의 침투 메커니즘은 주위 pH의 영향을 많이 받았으며, 젤의 $pK_a$ 보다 높은 pH인 7.0에서는 침투 메커니즘이 상대적으로 고분자사슬의 이완에 의한 지배를 많이 받는다는 것을 알 수 있었다. 한편, pH 7.0에서 고분자 이완에 의한 용매의 침투 메커니즘은 하이드로젤에 존재하는 카르복실산의 이온화에 기인한 것임을 ATR-FTIR 분광분석을 이용하여 확인하였다.

• Clinical and Experimental Pediatrics
• /
• 제46권5호
• /
• pp.454-458
• /
• 2003

목 적 : 신생아 로타바이러스 위장염의 빈도는 영유아와는 달리 계절적 유행 없이 일정하게 발생하며 임상 증상은 다양하여 무증상에서부터 구토, 설사 및 발열 드물게는 괴사성 장염과 출혈성 위장염 등을 나타낸다. 저자들은 건강한 만삭 신생아에서의 로타바이러스 원내 감염과 그 관련 요소에 대해 연구하였으며 본원에서 발생한 정상 신생아실의 만삭아에서 수유 및 분만 방법에 따른 증상의 빈도를 비교하여 이들의 연관성을 알아보고자 하였다. 방 법: 2001년 1월부터 6월까지 동국대학교병원에서 출생한 생후 7일 이내의 건강한 만삭 신생아 총 348명 중 증상을 보인 환아를 대상으로 시행한 변 rotazyme 검사에서 양성으로 확진된 환아 총 152례를 대상으로 연구하였으며 환아에 대한 각각의 항목은 병력지를 통하여 검토되었다. 환아 중 패혈증이나 뇌수막염, 요로 감염, 위식도 역류 및 황달 등이 있는 환아는 본 연구에서 제외되었다. 분만 방법은 정상 질식분만과 제왕절개술, 수유 방법은 모유와 분유로 구분해서 조사하였다. 분만 방법 및 수유 방법에 따른 로타바이러스 장염 신생아의 증상, 증상 기간에 대한 유의성을 통계적 Chi-square testd와 Fisher's exact test 및 Multiple logistic regression analysis로 검정하였으며 P<0.05인 경우를 유의 하다고 판정하였다. 결 과: 2001년 1월부터 6월까지 정상 만삭 출생아 중 입원 환아를 제외한 총 348명 중에서 로타바이러스 장염으로 확진 된 환아는 총 152명(43.7%)이었고, 그 중 남아는 95명(62.5%), 여아는 57명(37.5%)이었다. 체중이 2,500 g 이상이 149명(98.0%)이었고 모유 수유아는 97명(63.8%), 분유 수유아는 55명(36.2%)였고 분만 방법에서 정상 질식분만아는 22명(14.5%), 제왕절개아는 130명(85.5%)이었다. 증상은 미열이 51.3%로 가장 많았으며, 그 외 설사(40.8%), 복부 팽만(38.8%), 구토(35.5%) 등의 순 이었다. 증상 시작일이 생후 3-4일 이내인 경우가 134명(88.2%)이었으며 18명(11.8%)은 생후 5-7일째 증상이 나타났다. 증상 기간은 3일 이내인 경우가 120명(78.9%), 4-6일이 29명(19.1%), 7일 이상이 3명(2.0%)이었다. 모유 수유아에서 로타바이러스 장염의 증상의 빈도가 낮았고 분만 방법과 관련해서는 정상 질식 분만한 모유 수유아/분유 수유아에서 설사 11.1/84.6%, 수유 부진 22.2/69.2%, 체중 증가 지연 22.2/76.9%로 모유 수유아에서 증상 발현 빈도가 낮았고, 제왕절개분만 한 모유 수유아/분유 수유아에서는 정상 질식분만 한 환아에서와는 다르게 설사증상의 빈도는 차이가 없었으나 미열 45.5/66.7%, 복부 팽만 29.5/50.0%, 구토 31.8/60.9%, 체중 증가 지연 8.0/52.4%, 수유 부진 4.5/26.2%, 탈수 2.3/14.3%, 보챔 5.7/26.2%로 모유 수유아에서 증상의 빈도가 전반적으로 낮게 나타났으며 이는 통계적으로 유의성을 나타내었다(P<0.05). 결 론 : 로타바이러스 장염에 이환된 건강 만삭아의 분만 방법 및 수유 방법에 따른 로타바이러스 장염의 증상 차이에 대한 연구에서 모유 수유아에서 증상 발현빈도가 분유 수유아 보다 낮게 나타났다. 그러므로 모유 수유가 분유 수유보다 로타바이러스 장염의 증상을 완화시킬 수 있다고 생각된다.

• 치위생과학회지
• /
• 제16권3호
• /
• pp.249-255
• /
• 2016

본 사례보고는 대전 동구보건소에서 7년간 실시하고 있으며 매년 천 명 이상이 참가하는 노인 불소도포 스케일링 사업의 진행과 만족도, 논의사항 등을 보고하여 노인 구강보건사업 실행에 도움을 주고자 함이다. 2009년 시범사업은 대한노인회 대전동구지회와의 협의를 통해 각 경로당에 관련 공문을 보내고 신청 경로당에 직접 방문하거나 인근지역의 여러 경로당을 합하여 주민센터에서 사업을 진행하였으나 이후에는 경로당 중심 사업보다는 복지관이나 주민센터를 중심으로 진행하였다. 대전 동구치과의사회와 사전 협의 후 사업이 진행되었기 때문에 사업진행에 문제가 없었으나, 스케일링 후 지혈이 되지 않는 1건의 의료사고가 있었으며 이후로 지혈관련 전신질환이나 약물복용에 관한 사전 조사를 강화하였다. 2013년 본 사업에 대한 만족도 조사 동의자 355명 중 홍보 95.2%, 대기시간 73.2%, 스케일링 99.7%, 불소도포 91.5%, 틀니관리교육 96.6%, 칫솔질교육 98.6%가 만족한다고 하였다. 사업 참여 이유에 대한 구두대면조사 대상자 137명 중 44.9%는 무료라서, 12.5%는 치과에 가면 불필요한 치료를 받으라고 할까 봐 마음이 불편해서, 8.1%는 치과보다 제대로 치아관리를 해주는 것 같아서, 8.1%는 이동이 편리해서, 7.4%는 노인 우대를 잘 해주어서 등의 순으로 나타났다. 본 사업에 다시 참여하지 않겠다는 의견은 치과에 가서 하면 된다 1.5%, 다른 치료를 해주지 않는다 1.5%, 답변 거부 1.5% 등의 순으로 나타났다. 본 사업담당자의 의견은 사업의 지속적 참가자들의 구강환경관리 향상에 사업이 효율적이라 판단되나 농촌지역이나 취약계층 밀집지역의 경로당들은 사업 신청을 하지 않거나 신청인원 부족으로 사업의 효율성 때문에 배제되는 점, 스케일링의 보험급여화 이후 사업의 비용에 대한 고려가 필요하다고 하였다. 따라서, 취약계층을 사업에 포함하기 위한 방안 마련과 건강보험 급여화와 중복이 되는 보건소 사업에 대한 평가가 필요하다고 제안한다.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제35권2호
• /
• pp.112-119
• /
• 2009

Extracellular matrix(ECM) is known to function as a reservoir of endogenous growth factors, can be an effective delivery system of growth factor that easily lost bioactivity in solution. Fibrillar collagens like type I collagen, are the major constituent of the ECM and structural protein of bone. Also, it can be a scaffold for osteoblast migration. The purpose of this study was to compare the effects of absorbable Atelo-collagen Sponge($Teruplug^{(R)}$) insertion in tooth extraction sites on periodontal healing of the mandibular second molar after the extraction of the impacted third molar. The study population comprised 31 cases who had been scheduled for surgical removal of impacted mandibular third molars. All patients were in good general health and were not using any medication that would influence wound healing after surgery. In 15 cases control group, none was inserted into the tooth extraction site. In 16 cases experimental groups, $Teruplug^{(R)}$ was inserted into the tooth extraction site. We evaluated tooth mobility, pocket depth, gingival margin level preoperatively and 1 week, 2 weeks, 4 weeks, and 3 months postoperatively. The change was compared with two groups using Mann-Whitney test. The results were as follows. 1. There was no significant change of tooth mobility on both groups. 2. There was tendency of decreasing of previous pocket depth causing tooth extraction on both groups. 3. On gingival margin level, there was various change according to initial swelling and loss of attachment on both groups. 4. There was tendency of decreasing of gingival margin level on both groups because of removal of inflammation and decreasing of previous pocket depth. 5. There was large change of pocket depth on buccal middle, distal, lingual distal area because of tooth extraction and bone reduction. Compared with the control group and experimental group, we observed significant difference during some periods. The results of this study suggest that absorbable atelo-collagen sponge($Teruplug^{(R)}$) is relatively favorable bone void filler with prevention of tissue collapse, food packing and enhance periodontal healing.